Doctor Oliver Cohen
National Amyloidosis Centre, Royal Free Hospital, London (United Kingdom of Great Britain & Northern Ireland)
Global longitudinal strain predicts survival and response in patients with systemic AL amyloidosis. analysis of 915 patients from the ALchemy prospective trial
Event: ESC Congress 2020
Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)
Session: Blockbusters from the Young in Heart Failure
